FMCG major Dabur is aiming to double its sales to Rs 7,000 crore in the next four years as it plans to focus on strengthening the healthcare segment, making it one of the key growth drivers. “Dabur plans to double its sales and profits from current levels to reach Rs 7,000 crore from Rs 1,000 crore respectively by March 2014. Under the domestic healthcare business expansion strategy, the company plans to enter several new therapeutic areas with a strong branded presence in new over-the-counter categories,” says Anand Burman, Chairman, Dabur India. As per the new roadmap, Dabur is looking at expanding its healthcare category besides growing the food, home and personal care businesses. Some of the new categories the company is looking at are dermatology (skin), gastroenteritis, cough and cold, women’s healthcare, heart and metabolism, pain management and vitamins, minerals and supplements. At present, Dabur’s healthcare business stands around
Rs800 crore, while its personal care and food category is over Rs 1,700 crore and Rs 400 crore respectively.
Posted on :8-9-2010